|
|
Volumn 18, Issue 7, 2012, Pages 1001-
|
|
After Xigris, researchers look to new targets to combat sepsis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOFAB;
CYTOKINE;
DROTRECOGIN;
ERITORAN;
BLOOD CLOTTING;
COST BENEFIT ANALYSIS;
DRUG TREATMENT FAILURE;
HUMAN;
IMMUNITY;
INFLAMMATION;
INNATE IMMUNITY;
NOTE;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEPSIS;
ANTI-INFECTIVE AGENTS, LOCAL;
CLINICAL TRIALS AS TOPIC;
HUMANS;
PROTEIN C;
RECOMBINANT PROTEINS;
RESEARCH PERSONNEL;
SEPSIS;
|
|
EID: 84863712115
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0712-1001 Document Type: Note |
|
Times cited : (54)
|
|
References (0)
|
